Amir Emamifar, PharmD, MBA, Vice President and Chief Pharmacy Officer at Temple University Health System, shared five changes he would like to see in hospital pharmacy in 2022 with Becker’s Hospital Review.
Amir Emamifar, PharmD, MBA, Vice President and Chief Pharmacy Officer at Temple University Health System, shared five changes he would like to see in hospital pharmacy in 2022 with Becker’s Hospital Review.
Patients who received tezepelumab vs. placebo had less healthcare resource utilization; and fewer patients on tezepelumab vs. placebo received systemic corticosteroids for COPD exacerbations.
Read MoreThe analysis looked at sotatercept use in patients with pulmonary arterial hypertension and the safety and utilization across phenotype groups.
Read More